Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
ReplyCorrespondence

Dr. Cauli, et al reply

ALBERTO CAULI, DAFNA D. GLADMAN, ALESSANDRO MATHIEU, GIOVANNI PORRU, ALESSANDRA VACCA and PHILIP J. MEASE
The Journal of Rheumatology March 2012, 39 (3) 654; DOI: https://doi.org/10.3899/jrheum.111194
ALBERTO CAULI
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cauli@medicina.unica.it
DAFNA D. GLADMAN
MD, FRCPC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALESSANDRO MATHIEU
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GIOVANNI PORRU
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALESSANDRA VACCA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PHILIP J. MEASE
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

To the Editor:

We thank Dr. Kavanaugh, Dr. Catalan, and Dr. Cassell for their insightful comments and new data on nail involvement and patient’s perception of disease in psoriatic arthritis (PsA)1. We read with great interest their report, which supports the usefulness of patient self-assessment by means of visual analog scale (VAS) in the evaluation of PsA nail disease.

Assessment of PsA is challenging because of its varied clinical manifestations including skin, peripheral joints, axial disease, enthesitis, dactylitis, and last but not least, nail disease. Recently, GRAPPA and OMERACT have reached a consensus on a core set of domains to be evaluated in randomized controlled trials and longitudinal observational trials2, but which were recommended also for rheumatology clinics focusing on PsA. Six domains were selected: peripheral joint activity, skin activity, pain, patient global assessment, physical function, and health-related quality of life. Other domains, including nail diseases (and spinal disease, dactylitis, enthesitis, fatigue, radiography, physician global assessment, acute-phase reactants), were considered important but not mandatory.

Patient perception of disease was therefore confined to global assessment of disease (the PGA). Nevertheless, because patient’s perspective is affected by all the different manifestations of the disease, it was also recommended that a specific study should be performed to determine if patient global assessment of disease activity is sufficient or if we should also assess the effect of skin and joint involvement, as the main manifestations of disease, segregated into 2 separate questions. Many members noted that 3 VAS questionnaires were too many to be administered to patients, even in a research setting, and therefore separate VAS questionnaires for all the different manifestations of PsA were not considered. GRAPPA set up a working group of 18 centers in 10 countries in order to assess this issue3.

In this multicenter GRAPPA study, nail involvement was not included in the protocol but was evaluated in a subset of 40 patients from the outpatient clinic of the University of Cagliari. Nail involvement was assessed as “modified Nail Psoriasis Severity Index” (mNAPSI)4 and as “physician nail assessment” by means of a 0–100 mm VAS. Patient male/female ratio was 28/12, mean age was 49.3 ± 13.9 years, and mean disease duration was 13.5 ± 11.3 years for skin and 10.1 ± 7.6 years for joints. Pairwise correlations between nail involvement and several outcome measures, in particular the skin and joint objective evaluations as well as patients’ and physicians’ perception of disease, have been calculated using Spearman’s rho statistic (Table 1).

View this table:
  • View inline
  • View popup
Table 1.

Nail involvement and outcome measures for psoriatic arthritis.

In our cohort of patients we observed a strong correlation between the 2 instruments used to evaluate nail involvement: the mNAPSI and “physician nail assessment”; further, we observed a significant correlation between nail involvement and skin disease, evaluated by the PASI. On the other hand we did not observe a significant correlation with joint disease or with global PsA activity. It is nevertheless noteworthy, as emphasized by Kavanaugh, et al1, that some differences may be observed according to the cohort studied.

Detailed assessment of all the domains of PsA (including nails) is important in order to provide better care to patients. This requires implementation of a set of instruments, specific for each of the domains, which must be “feasible” for the patient and the treating physician, otherwise they would not be applied in the clinic or even in research studies. The patient’s perception of disease is well summarized by the PGA, which is an acceptable single measure for clinical trials and clinical practice; in certain circumstances, such as the study of a drug that may improve the joints but not the skin, or vice versa, it would be important to also assess the patient-specific perception of joint and skin disease. Similarly, specific circumstances may also induce the physician to evaluate the patient’s specific perception of nail involvement, dactylitis, or enthesitis.

REFERENCES

  1. 1.↵
    1. Kavanaugh A,
    2. Catalan T,
    3. Cassell S
    . Patient assessments of skin, joint, and nail disease activity in psoriatic arthritis [letter]. J Rheumatol 2012;39:653–4.
    OpenUrlFREE Full Text
  2. 2.↵
    1. Gladman DD,
    2. Mease PJ,
    3. Healy P,
    4. Helliwell PS,
    5. FitzGerald O,
    6. Cauli A,
    7. et al.
    Outcome measures in psoriatic arthritis. J Rheumatol 2007;34:1159–66.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Cauli A,
    2. Gladman DD,
    3. Mathieu A,
    4. Olivieri I,
    5. Porru G,
    6. Tak PP,
    7. et al.
    Patient global assessment in psoriatic arthritis: A multicenter GRAPPA and OMERACT study. J Rheumatol 2011;38:898–903.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Cassell S,
    2. Bieber J,
    3. Rich P,
    4. Tutuncu Z,
    5. Lee SJ,
    6. Kalunian K,
    7. et al.
    The modified Nail Psoriasis Severity Index: Validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J Rheumatol 2007;34:123–9.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 39, Issue 3
1 Mar 2012
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Dr. Cauli, et al reply
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Dr. Cauli, et al reply
ALBERTO CAULI, DAFNA D. GLADMAN, ALESSANDRO MATHIEU, GIOVANNI PORRU, ALESSANDRA VACCA, PHILIP J. MEASE
The Journal of Rheumatology Mar 2012, 39 (3) 654; DOI: 10.3899/jrheum.111194

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Dr. Cauli, et al reply
ALBERTO CAULI, DAFNA D. GLADMAN, ALESSANDRO MATHIEU, GIOVANNI PORRU, ALESSANDRA VACCA, PHILIP J. MEASE
The Journal of Rheumatology Mar 2012, 39 (3) 654; DOI: 10.3899/jrheum.111194
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Dr. Yoshida et al reply
  • A Rare Case of Parvovirus B19-Induced Atlantoaxial Arthritis
  • Dr. Solomon et al reply
Show more Correspondence

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire